ClinicalTrials.gg
Drug

Omadacycline clinical trials

Also written Nuzyra and PTK 0796.

studies test it
21
open now
3
in phase 3
7
first study started
2007

How each study uses omadacycline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the omadacycline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Oct 2018 · NUZYRA · NDA 209816 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Omadacycline
10
Omadacycline Oral Tablet
5

Brand

Nuzyra
8

Development codes

PTK 0796
3

Studies by the year they started

20 studies that test it; most in 2021 (3); 1 more planned to start later

Studies that test omadacycline, by start year
YearStudies
20071
20092
20152
20161
20182
20191
20202
20213
20221
20233
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
6
Phase 3
7
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 7

Paratek Pharmaceuticals Inc (12) · Zai Lab (Hong Kong), Ltd. (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Paul Beringer (1) · University of Houston (1) · Wake Forest University Health Sciences (1) · Hartford Hospital (1) · Vancouver Coastal Health (1)

Often tested with

Tested in the same studies.

Amikacin (1) · Clofazimine (1) · Bedaquiline (1) · Linezolid (1) · Sulfamethoxazole (1) · Trimethoprim (1) · Imipenem (1) · Cilastatin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test omadacycline.

Studies

Open first, then newest update. How each study uses omadacycline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test omadacycline →

Codes

What other systems call omadacycline · ClinicalTrials.gg INT000071

  • MeSH (NLM) C000591640omadacyclineOne source NLM
  • UNII (FDA) 090IP5RV8FOMADACYCLINEConfirmed FDA, NLM
  • RxNorm 2059269One source FDA
  • NCI Thesaurus C90688OmadacyclineOne source FDA

Also registered as omadacycline tosylate (UNII 5658Y89YCD · RxNorm 2059268).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.